Abstract
Objectives
To evaluate breast biopsy marker migration in stereotactic core needle biopsy procedures and identify contributing factors.
Methods
This retrospective study analyzed 268 stereotactic biopsy markers placed in 263 consecutive patients undergoing stereotactic biopsies using 9G vacuum-assisted devices from August 2010-July 2013. Mammograms were reviewed and factors contributing to marker migration were evaluated. Basic descriptive statistics were calculated and comparisons were performed based on radiographically-confirmed marker migration.
Results
Of the 268 placed stereotactic biopsy markers, 35 (13.1%) migrated ≥1 cm from their biopsy cavity. Range: 1–6 cm; mean (± SD): 2.35 ± 1.22 cm. Of the 35 migrated biopsy markers, 9 (25.7%) migrated ≥3.5 cm. Patient age, biopsy pathology, number of cores, and left versus right breast were not associated with migration status (P> 0.10). Global fatty breast density (P= 0.025) and biopsy in the inner region of breast (P = 0.031) were associated with marker migration. Superior biopsy approach (P= 0.025), locally heterogeneous breast density, and t-shaped biopsy markers (P= 0.035) were significant for no marker migration.
Conclusions
Multiple factors were found to influence marker migration. An overall migration rate of 13% supports endeavors of research groups actively developing new biopsy marker designs for improved resistance to migration.
Key Points
• Breast biopsy marker migration is documented in 13% of 268 procedures.
• Marker migration is affected by physical, biological, and pathological factors.
• Breast density, marker shape, needle approach etc. affect migration.
• Study demonstrates marker migration prevalence; marker design improvements are needed.
Similar content being viewed by others
Abbreviations
- BI-RADS:
-
Breast Imaging-reporting and data system
- SD:
-
Standard deviation
References
Burbank F, Forcier N (1997) Tissue marking clip for stereotactic breast biopsy: initial placement accuracy, long-term stability, and usefulness as a guide for wire localization. Radiology 205:407–415
Liberman L, Dershaw DD, Morris EA, Abramson AF, Thornton CM, Rosen PP (1997) Clip placement after stereotactic vacuum-assisted breast biopsy. Radiology 205:417–422
Reynolds HE (1999) Marker clip placement following directional, vacuum-assisted breast biopsy. Am Surg 65:59–60
Rosen EL, Vo TT (2001) Metallic clip deployment during stereotactic breast biopsy: retrospective analysis. Radiology 218:510–516
Kruger BM, Burrowes P, MacGregor JH (2002) Accuracy of marker clip placement after mammotome breast biopsy. Can Assoc Radiol J 53:137–140
Millman SLMC, Pile-Spellman ER, Higgins HM, Smith SJ (2002) Accuracy of clip placement using the 11 gauge ultrasound-guided hand-held mammotome device (abstr). AJR Am J Roentgenol 178:61
Esserman LE, Cura MA, DaCosta D (2004) Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuum-assisted biopsy. Radiographics 24:147–156
Birdwell RL, Jackman RJ (2003) Clip or marker migration 5–10 weeks after stereotactic 11-gauge vacuum-assisted breast biopsy: report of two cases. Radiology 229:541–544
Burnside ES, Sohlich RE, Sickles EA (2001) Movement of a biopsy-site marker clip after completion of stereotactic directional vacuum-assisted breast biopsy: case report. Radiology 221:504–507
Parikh J (2004) Ultrasound demonstration of clip migration to Skin within 6 weeks of 11-gauge vacuum-assisted stereotactic breast biopsy. Breast J 10:539–542
Parikh JR (2005) Delayed migration of Gel Mark Ultra clip within 15 days of 11-gauge vacuum-assisted stereotactic breast biopsy. AJR Am J Roentgenol 185:203–206
Philpotts LE, Lee CH (2002) Clip migration after 11-gauge vacuum-assisted stereotactic biopsy: case report. Radiology 222:794–796
Kaplan JA, Grinstaff MW, Bloch BN (2016) Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers. Eur Radiol 26:866–873
Siegmann KC, Speck S, Baur A et al (2009) Performance of a newly developed clip (Tumark Professional) for MRI-guided lesion localization after MRI-guided vacuum-assisted biopsy--first results. Röfo 181:147–154
Viehweg P, Fabel K, Petzold A, Friedrich K, Laniado M (2007) O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy--first results. Röfo 179:1055–1060
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The scientific guarantor of this publication is Dr. B. Nicolas Bloch.
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Funding
The authors state that this work has not received any funding.
Statistics and biometry
No complex statistical methods were necessary for this paper.
Informed consent
Written informed consent was waived by the Institutional Review Board.
Ethical approval
Institutional Review Board approval was obtained.
Study subjects or cohorts overlap
Some study subjects or cohorts have been previously reported at the European Congress of Radiology in 2014 and 2016.
Methodology
• retrospective
• cross-sectional study
• performed at one institution
Additional information
Ashali Jain and Maria Khalid contributed equally to this work.
Rights and permissions
About this article
Cite this article
Jain, A., Khalid, M., Qureshi, M.M. et al. Stereotactic core needle breast biopsy marker migration: An analysis of factors contributing to immediate marker migration. Eur Radiol 27, 4797–4803 (2017). https://doi.org/10.1007/s00330-017-4851-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-017-4851-7